Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71050 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Paul-Elie Gosset und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Hepatitis C, Hepacivirus, Hepatitis C Antibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Early diagnosis of Hepatitis C virus (HCV) infection is a cornerstone of elimination strategies. Fourth‐generation antigen/antibody combination assays, such as Elecsys HCV Duo, promise to bridge the diagnostic gap left by antibody‐only testing. In this real‐world study, we assessed Elecsys HCV Duo performance using seroconversion panels and routine clinical samples, focusing on sensitivity, specificity, and positive predictive value (PPV) for active HCV detection, including challenging scenarios with low viral loads and HIV co‐infections. The assay shortened the serological window by up to 203 days. When both antigen and antibody were detected, PPV reached 100%, enabling confident diagnosis without immediate RNA confirmation. The antigen component alone achieved a PPV of 97.6%, even in a low‐prevalence setting (0.33%), better than previously reported assays. However, sensitivity for low viral loads (≤ 5 log 10 IU/mL) was limited, with 95.5% of such cases missed. Elecsys HCV Duo offers a powerful tool for earlier detection and streamlined care, particularly in high‐risk and resource‐limited contexts. Yet, confirmatory RNA testing remains essential for low viral load cases. Broader validation is needed to confirm its utility in diverse populations, reinfection surveillance, and cost‐effective screening strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology, Hospices Civils de Lyon, Lyon, France.
- Université de Lyon, Lyon 1 Université, Lyon, France.
- Lyon Hepatology Institute, IHU EVEREST, Lyon, France.
- Department of Virology, INSERM Unit 1111, CIRI, Hospices Civils de Lyon, Lyon, France.
- Department of Hepatology, INSERM Unit 1350 PathLiv, Hospices Civils de Lyon, Lyon, France.
- Department of Virology, INSERM Unit 1350 PathLiv, Hospices Civils de Lyon, Lyon, France.
ORCID-Profile: Christophe Ramière, Caroline Scholtès
Zitieren
APA
Gosset, P. E., Margueron-Sentis, C., Ramière, C., Zoulim, F., & Scholtès, C. (2026). Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study. Journal of Medical Virology. https://doi.org/10.1002/jmv.71050
Vancouver
Gosset PE, Margueron-Sentis C, Ramière C, Zoulim F, Scholtès C. Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study. Journal of Medical Virology. 2026. doi:10.1002/jmv.71050
BibTeX
@article{Gosset2026,
author = {Gosset, Paul-Elie and Margueron-Sentis, Célia and Ramière, Christophe and Zoulim, Fabien and Scholtès, Caroline},
title = {Comprehensive Evaluation of the Elecsys HCV Duo Immunoassay for Active Hepatitis C Detection: Insights From the DEPCDUO Study},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71050}
}
EUVIMED